 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Ligase
|
 |
|
Title:
|
 |
Crystal structure of human argininosuccinate synthase in com aspartate and citrulline
|
|
Structure:
|
 |
Argininosuccinate synthase. Chain: a. Synonym: citrulline--aspartate ligase. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: ass1, ass. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
|
|
Biol. unit:
|
 |
Tetramer (from PDB file)
|
|
Resolution:
|
 |
|
2.40Å
|
R-factor:
|
0.198
|
R-free:
|
0.265
|
|
|
Authors:
|
 |
T.Karlberg,J.Uppenberg,C.Arrowsmith,H.Berglund,R.D.Busam,R.C A.Edwards,U.B.Ericsson,S.Flodin,A.Flores,S.Graslund,B.M.Hal M.Hammarstrom,M.Hogbom,I.Johansson,T.Kotenyova,A.Magnusdott M.Moche,M.E.Nilsson,P.Nordlund,T.Nyman,D.Ogg,C.Persson,J.Sa P.Stenmark,M.Sundstrom,A.G.Thorsell,S.Van Den Berg,K.Wallde J.Weigelt,L.Holmberg-Schiavone,Structural Genomics Consorti
|
Key ref:
|
 |
T.Karlberg
et al.
(2008).
Structure of human argininosuccinate synthetase.
Acta Crystallogr D Biol Crystallogr,
64,
279-286.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
22-Nov-06
|
Release date:
|
05-Dec-06
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
P00966
(ASSY_HUMAN) -
Argininosuccinate synthase
|
|
|
|
Seq: Struc:
|
 |
 |
 |
412 a.a.
402 a.a.
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.6.3.4.5
- Argininosuccinate synthase.
|
|
 |
 |
 |
 |
 |

Pathway:
|
 |
Urea Cycle and Arginine Biosynthesis
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + L-citrulline + L-aspartate = AMP + diphosphate + N(omega)- (L-arginino)succinate
|
 |
 |
 |
 |
 |
ATP
|
+
|
L-citrulline
Bound ligand (Het Group name = )
corresponds exactly
|
+
|
L-aspartate
Bound ligand (Het Group name = )
corresponds exactly
|
=
|
AMP
|
+
|
diphosphate
|
+
|
N(omega)- (L-arginino)succinate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
cell body fiber
|
11 terms
|
 |
|
Biological process
|
cellular response to lipopolysaccharide
|
36 terms
|
 |
|
Biochemical function
|
nucleotide binding
|
6 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Acta Crystallogr D Biol Crystallogr
64:279-286
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of human argininosuccinate synthetase.
|
|
T.Karlberg,
R.Collins,
S.van den Berg,
A.Flores,
M.Hammarström,
M.Högbom,
L.Holmberg Schiavone,
J.Uppenberg.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Argininosuccinate synthetase catalyzes the transformation of citrulline and
aspartate into argininosuccinate and pyrophosphate using the hydrolysis of ATP
to AMP and pyrophosphate. This enzymatic process constitutes the rate-limiting
step in both the urea and arginine-citrulline cycles. Previous studies have
investigated the crystal structures of argininosuccinate synthetase from
bacterial species. In this work, the first crystal structure of human
argininosuccinate synthetase in complex with the substrates citrulline and
aspartate is presented. The human enzyme is compared with structures of
argininosuccinate synthetase from bacteria. In addition, the structure also
provides new insights into the function of the numerous clinical mutations
identified in patients with type I citrullinaemia (also known as classic
citrullinaemia).
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2 The substrates citrulline and aspartate modelled into
the electron density. Human argininosuccinate synthetase (hASS)
was cocrystallized with the two substrate molecules citrulline
and aspartate. [A]-weighted
2F[obs] - F[calc] density at 2.4 Å resolution is shown for
these ligands. The ligand-protein interactions for hASS closely
resemble those reported previously for bacterial structures. All
figures were produced using PyMOL (DeLano, 2002[DeLano, W. L.
(2002). The PyMOL User's Manual. DeLano Scientific, San Carlos,
USA.]).
|
 |
Figure 4.
Figure 4 Cys132 and nitrosylation. The side chain of Cys132 is
nitrosylated by nitric oxide synthase (NOS) as a down-regulating
feedback mechanism (Hao et al., 2004[Hao, G., Xie, L. & Gross,
S. S. (2004). J. Biol. Chem. 279, 36192-36200.]). NOS and
argininosuccinate synthetase belong to the same pathway, the
arginine-citrulline cycle. (a) In the nonnitrosylated structure
of human ASS, the cysteine side chain is not located in the
immediate vicinity of the active site. A small cavity, here
shown as a van der Waals surface, is found next to the
side-chain sulfur. (b) A group of nitrosylated cysteine residues
found on proteins in the Protein Data Bank have been
superimposed with Cys132.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the IUCr:
Acta Crystallogr D Biol Crystallogr
(2008,
64,
279-286)
copyright 2008.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.J.Perez,
J.Jaubert,
J.L.Guénet,
K.F.Barnhart,
C.M.Ross-Inta,
V.C.Quintanilla,
I.Aubin,
J.L.Brandon,
N.W.Otto,
J.DiGiovanni,
I.Gimenez-Conti,
C.Giulivi,
D.F.Kusewitt,
C.J.Conti,
and
F.Benavides
(2010).
Two hypomorphic alleles of mouse Ass1 as a new animal model of citrullinemia type I and other hyperammonemic syndromes.
|
| |
Am J Pathol, 177,
1958-1968.
|
 |
|
|
|
|
 |
J.R.Guerreiro,
C.Lameu,
E.F.Oliveira,
C.F.Klitzke,
R.L.Melo,
E.Linares,
O.Augusto,
J.W.Fox,
I.Lebrun,
S.M.Serrano,
and
A.C.Camargo
(2009).
Argininosuccinate synthetase is a functional target for a snake venom anti-hypertensive peptide: role in arginine and nitric oxide production.
|
| |
J Biol Chem, 284,
20022-20033.
|
 |
|
|
|
|
 |
K.Engel,
W.Höhne,
and
J.Häberle
(2009).
Mutations and polymorphisms in the human argininosuccinate synthetase (ASS1) gene.
|
| |
Hum Mutat, 30,
300-307.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
|